podophyllotoxin has been researched along with 9-((2-phosphonylmethoxy)ethyl)guanine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrei, G; Birkus, G; Christensen, ND; Doerrfler, E; Lee, WA; Ray, AS; Reiser, H; Shibata, R; Snoeck, R; Wang, J; Wolfgang, GH; Wu, S | 1 |
1 other study(ies) available for podophyllotoxin and 9-((2-phosphonylmethoxy)ethyl)guanine
Article | Year |
---|---|
GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Female; Guanine; Humans; Male; Nucleic Acid Synthesis Inhibitors; Phenylalanine; Prodrugs; Rabbits; Uterine Cervical Neoplasms | 2009 |